To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease (2009)
- Authors:
- USP affiliated authors: GATTAZ, WAGNER FARID - FM ; FORLENZA, ORESTES VICENTE - FM
- Unidade: FM
- DOI: 10.1007/s00406-008-0864-1
- Subjects: METANÁLISE; DOENÇA DE ALZHEIMER; EVOLUÇÃO CLÍNICA; TRANSTORNOS COGNITIVOS (TERAPIA)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: European Archives of Psychiatry and Clinical Neurosciences
- ISSN: 0940-1334
- Volume/Número/Paginação/Ano: v. 259, n. 4, p. 248-256, 2009
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
DINIZ, Breno Satler et al. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease. European Archives of Psychiatry and Clinical Neurosciences, v. 259, n. 4, p. 248-256, 2009Tradução . . Disponível em: https://doi.org/10.1007/s00406-008-0864-1. Acesso em: 18 abr. 2024. -
APA
Diniz, B. S., Pinto Junior, J. A., Gonzaga, M. L. C., Guimarães, F. M., Gattaz, W. F., & Forlenza, O. V. (2009). To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease. European Archives of Psychiatry and Clinical Neurosciences, 259( 4), 248-256. doi:10.1007/s00406-008-0864-1 -
NLM
Diniz BS, Pinto Junior JA, Gonzaga MLC, Guimarães FM, Gattaz WF, Forlenza OV. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease [Internet]. European Archives of Psychiatry and Clinical Neurosciences. 2009 ; 259( 4): 248-256.[citado 2024 abr. 18 ] Available from: https://doi.org/10.1007/s00406-008-0864-1 -
Vancouver
Diniz BS, Pinto Junior JA, Gonzaga MLC, Guimarães FM, Gattaz WF, Forlenza OV. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease [Internet]. European Archives of Psychiatry and Clinical Neurosciences. 2009 ; 259( 4): 248-256.[citado 2024 abr. 18 ] Available from: https://doi.org/10.1007/s00406-008-0864-1 - Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study
- A radioenzymatic assay to identify three groups of phospholipase A2 in platelets
- Interleukin-1β Serum Levels is Increased in Antidepressant-Free Elderly Depressed Patients
- Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study
- Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study
- Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients
- Long-Term Lithium Treatment Increases cPLA2 and iPLA2 Activity in Cultured Cortical and Hippocampal Neurons
- Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study
- Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein
Informações sobre o DOI: 10.1007/s00406-008-0864-1 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
